MAL and TMEM220 are novel DNA methylation markers in human gastric cancer

References

• Ahlquist DA, Zou H, Domanico M, et al. (2012). Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 142:248–56 (quiz e25-6).
   PubMed Web of Science ®Google Scholar
• Akhavan-Niaki H, Samadani AA. (2013). DNA methylation and cancer development: molecular mechanism. Cell Biochem Biophys 67:501–13.
   PubMed Web of Science ®Google Scholar
• Ando T, Yoshida T, Enomoto S, et al. (2009). DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 124:2367–74.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. (2001). Inflammation and cancer: back to Virchow? Lancet 357:539–45.
   PubMed Web of Science ®Google Scholar
• Ball MP, Li JB, Gao Y, et al. (2009). Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 27:361–8.
   PubMed Web of Science ®Google Scholar
• Ben Gacem R, Ben Abdelkrim O, Ziadi S, et al. (2014). Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease. Tumour Biol 35:4047–56.
   PubMed Web of Science ®Google Scholar
• Buffart TE, Overmeer RM, Steenbergen RD, et al. (2008). MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer 99:1802–7.
   PubMed Web of Science ®Google Scholar
• Chen H, Xu Z. (2015). Hypermethylation-associated silencing of miR-125a and miR-125b: a potential marker in colorectal cancer. Disease Markers 2015:345080.
   PubMed Web of Science ®Google Scholar
• Chiba T, Marusawa H, Ushijima T. (2012). Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 143:550–63.
   PubMed Web of Science ®Google Scholar
• EL-Sedfy A, Brar SS, Coburn NG. (2014). Current role of minimally invasive approaches in the treatment of early gastric cancer. World J Gastroenterol 20:3880–8.
   PubMed Web of Science ®Google Scholar
• Esteller M. (2008). Epigenetics in cancer. N Engl J Med 358:1148–59.
   PubMed Web of Science ®Google Scholar
• Gronbaek K, Treppendahl M, Asmar F, Guldberg P. (2008). Epigenetic changes in cancer as potential targets for prophylaxis and maintenance therapy. Basic Clin Pharmacol Toxicol 103:389–96.
   PubMed Web of Science ®Google Scholar
• Guggenheim DE, Shah MA. (2013). Gastric cancer epidemiology and risk factors. J Surg Oncol 107:230–6.
   PubMed Web of Science ®Google Scholar
• Hassler MR, Klisaroska A, Kollmann K, et al. (2012). Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma. Biochimie 94:2297–307.
   PubMed Web of Science ®Google Scholar
• Hibi K, Sakata M, Sakuraba K, et al. (2010). Methylation of the DCC gene is lost in advanced gastric cancer. Anticancer Res 30:107–9.
   PubMed Web of Science ®Google Scholar
• Horne HN, Lee PS, Murphy SK, et al. (2009). Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy. Mol Cancer Res 7:199–209.
   PubMed Web of Science ®Google Scholar
• Jang BG, Kim WH. (2011). Molecular pathology of gastric carcinoma. Pathobiology 78:302–10.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin 61:69–90.
   PubMed Web of Science ®Google Scholar
• Jung KW, Won YJ, Kong HJ, et al. (2015). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 47:127–41.
   PubMed Web of Science ®Google Scholar
• Kitajima Y, Ohtaka K, Mitsuno M, et al. (2008). Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol Rep 19:197–202.
   PubMed Web of Science ®Google Scholar
• Li LY, Li JK, Shen Y, et al. (2008). [Promoter methylation and expression of Runx3 gene in gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 11:379–82.
   PubMedGoogle Scholar
• Lind GE, Ahlquist T, Kolberg M, et al. (2008). Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. J Transl Med 6:13.
   PubMed Web of Science ®Google Scholar
• Liu WT, Jiao HL, Yang YL, et al. (2007). [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer]. Ai Zheng 26:1199–203.
   PubMedGoogle Scholar
• Lv Z, Fan Y, Chen H, Zhao D. (2014). Endothelial cell-specific molecule-1: a potential serum marker for gastric cancer. Tumour Biol 35:10497–502.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. (2008). Cancer-related inflammation. Nature 454:436–44.
   PubMed Web of Science ®Google Scholar
• Mikeska T, Craig JM. (2014). DNA methylation biomarkers: cancer and beyond. Genes 5:821–64.
   PubMed Web of Science ®Google Scholar
• Mimori K, Shiraishi T, Mashino K, et al. (2003). MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway. Oncogene 22:3463–71.
   PubMed Web of Science ®Google Scholar
• Mishra A, Verma M. (2010). Cancer biomarkers: are we ready for the prime time? Cancers 2:190–208.
   PubMedGoogle Scholar
• Nakajima T, Akiyama Y, Shiraishi J, et al. (2001). Age-related hypermethylation of the hMLH1 promoter in gastric cancers. Int J Cancer 94:208–11.
   PubMed Web of Science ®Google Scholar
• Oh JH, Jung SH, Hong SJ, Rhyu MG. (2015). DNA methylation as surrogate marker for gastric cancer. J Cancer Prevent 20:172–8.
   PubMedGoogle Scholar
• Overmeer RM, Henken FE, Bierkens M, et al. (2009). Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 219:327–36.
   PubMed Web of Science ®Google Scholar
• Pal SK, Noguchi S, Yamamoto G, et al. (2012). Expression of myelin and lymphocyte protein (MAL) in oral carcinogenesis. Med Mol Morphol 45:222–8.
   PubMed Web of Science ®Google Scholar
• Park JH, Park J, Choi JK, et al. (2011). Identification of DNA methylation changes associated with human gastric cancer. BMC Med Genomics 4:82
   PubMed Web of Science ®Google Scholar
• Reik W, Dean W. (2001). DNA methylation and mammalian epigenetics. Electrophoresis 22:2838–43.
   PubMed Web of Science ®Google Scholar
• Sakai E, Nakajima A, Kaneda A. (2014). Accumulation of aberrant DNA methylation during colorectal cancer development. World J Gastroenterol 20:978–87.
   PubMed Web of Science ®Google Scholar
• Sharma S, Kelly TK, Jones PA. (2010). Epigenetics in Cancer. Carcinogenesis 31:27–36.
   Google Scholar
• Shimada H, Noie T, Ohashi M, et al. (2014). Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 17:26–33.
   PubMed Web of Science ®Google Scholar
• Sidransky D. (2002). Emerging molecular markers of cancer. Nat Rev Cancer 2:210–19.
   PubMed Web of Science ®Google Scholar
• Szyf M. (2012). DNA methylation signatures for breast cancer classification and prognosis. Genome Med 4:26.
   PubMed Web of Science ®Google Scholar
• Tian Y, Wei W, Li L, Yang R. (2015). Down-regulation of miR-148a promotes metastasis by DNA methylation and is associated with prognosis of skin cancer by targeting TGIF2. Med Sci Monitor Int Med J Exp Clin Res 21:3798–805.
   Google Scholar
• Torano EG, Petrus S, Fernandez AF, Fraga MF. (2012). Global DNA hypomethylation in cancer: review of validated methods and clinical significance. Clin Chem Lab Med 50:1733–42.
   PubMed Web of Science ®Google Scholar
• Ushijima T, Nakajima T, Maekita T. (2006). DNA methylation as a marker for the past and future. J Gastroenterol 41:401–7.
   PubMed Web of Science ®Google Scholar
• Wanebo HJ, Kennedy BJ, Chmiel J, et al. (1993). Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218:583–92.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang F, Wu PP, et al. (2006). Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma. World J Gastroenterol 12:4228–31.
   PubMed Web of Science ®Google Scholar
• Wongtrakoongate P. (2015). Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries. World J Stem Cells 7:137–48.
   PubMed Web of Science ®Google Scholar
• Yeh JM, Goldie SJ, Kuntz KM, Ezzati M. (2009). Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections. Cancer Causes Control 20:2021–9.
   PubMed Web of Science ®Google Scholar
• Zelic R, Fiano V, Grasso C, et al. (2014). Global DNA hypomethylation in prostate cancer development and progression: a systematic review. Prostate Cancer Prostatic Dis 18:1–12.
   PubMed Web of Science ®Google Scholar
• Zhao C, Bu X. (2012). Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol Histopathol 27:1271–82.
   PubMed Web of Science ®Google Scholar
• Zhou YN, Xu CP, Han B, Ji R. (2005). [CpG island methylation of E-cadherin gene promoter in gastric carcinoma]. Ai Zheng 24:1220–4.
   PubMedGoogle Scholar
• Zou H, Allawi H, Cao X, et al. (2012). Quantification of methylated markers with a multiplex methylation-specific technology. Clin Chem 58:375–83.
   PubMed Web of Science ®Google Scholar